Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
The future of immunotherapy in prostate cancer
Charles G. Drake
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The future of immunotherapy in prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Active Immunotherapy
100%
Immunotherapy
67%
Prostatic Neoplasms
60%
Dendritic Cells
22%
Monoclonal Antibodies
18%
Antigens
16%
DNA
14%
Survival
14%
Therapeutics
4%